Markets
markets
J. Edward Moreno

Hims & Hers crash is just another opportunity for retail to buy the dip

Retail traders are still running toward Hims & Hers despite the company’s record one-day loss after Novo Nordisk called off its partnership with the telehealth company.

Over the past five days, Hims has been one of the most bought securities on Interactive Brokers, more than Palantir, Apple, or Amazon. Despite dropping more than 30% on the news, the move “attracted opportunistic buyers,” Interactive Brokers Chief Strategist Steve Sosnick wrote in a Tuesday note.

“It can take some time to learn whether dip buying is instead knife catching, so the situation in HIMS will take a few days to resolve,” he wrote.

Options activity on the platform has also been tilted to the bullish side over this stretch, per Interactive Brokers’ data.

Hims zigzagged a bit throughout Tuesday morning as investors continued to digest the news. While the partnership was never a revenue driver for Hims, it did quell worries about litigation risk and presented the prospect of future collaborations with the drugmaker.

More Markets

See all Markets
Luke Kawa
3h
The boom in sports gambling and prediction markets is creating “emerging credit risks,” per Bank of America

“For investors this convergence of entertainment and speculative finance signals heightened behavioral risk,” writes BofA.

Craps, Roulette and Sports Betting Debuts at Seminole Hard Rock Hotel & Casino Hollywood
Iren Cipher Mining Data Center Crypto Miners

JPMorgan lifts Cipher Mining to “overweight,” hikes Iren price target

The crypto-miner-turned-AI-data-center trade is back on Monday.

Matt Phillips3h
markets
Luke Kawa

Broadcom soars as rave reviews for Gemini 3 boost appeal of its custom chips

When spectators saw Michael Jordan blossom as a basketball star, it made them want to buy Nike’s Air Jordans.

Mizuho reckons there’s a similar halo effect for Broadcom based on the rave reviews for Google’s latest GenAI model, which include this ringing endorsement from Salesforce CEO Marc Benioff.

“Gemini 3 was trained and powered on Google homegrown TPU chips, which benefits partner AVGO,” wrote Daniel O’Regan, Mizuho’s managing director of equity trading.

Custom chips (ASICs) are Broadcom’s specialty, and as O’Regan noted, Google and Broadcom codesigned these building blocks for Gemini 3. Boosts to Google’s capex budget have tended to buoy shares of Broadcom, since it’s a big beneficiary of these outlays.

The early positive reception to Gemini 3 implies that: a) Google will want to continue this relationship (and need more chips for training and inference!), and b) other GenAI developers might be more willing to pursue the custom chip route for AI models and inference, perhaps eating into market share for Nvidia’s GPU-based solutions.

To this end, Broadcom announced a collaboration with OpenAI in mid-October to develop and deploy 10 gigawatts of custom AI accelerators.

Nvidia CEO Jensen Huang has argued that GPU-centric data center solutions are superior because of how ubiquitous the firm’s CUDA software is in high-performance computing.

markets
Matt Phillips

Citi ups Oklo price target as company executes “on all fronts”

Citi analysts lifted their price target for aspiring nuclear power provider Oklo Monday, after meeting with management last week.

They cited progress on the company’s reactor licensing strategy, its new radioactive fuel supply business — part of an acquisition that closed in March — as well as Oklo’s ability to borrow at lower-than-expected costs recently.

Analysts led by Vikram Bagri, who have a “neutral/high risk” rating on the stock, lifted their price target to $95 a share from $68. (It’s currently trading around $90.) They wrote:

“The company is executing on all fronts with new supply contracts for long lead time items, a dual-track licensing approach, diversification through its radioisotope business, and the exploration of new avenues for fuel procurement. We lift our target price as we incorporate radioisotope business.”

In particular, they spotlighted Oklo’s strategy of pursuing licensing for its reactors on parallel tracks with both the Nuclear Regulatory Commission — the traditional decider on all things nuclear in the US — and the Department of Energy, which under the Trump administration has begun issuing faster authorizations for initial development of experimental reactors, without applicants having to wait for full commercial approval of reactor plans from the NRC, as was previously typical. We recently wrote about that approach here.

Oklo has no revenue and Wall Street analysts don’t expect it to have any significant sales until 2028, when they project it will still be seeing losses.

David Crowther, Hyunsoo Rim
Way-Mo-Gems-to-come
4h
Google has smoked the rest of its Big Tech peers this year

Alphabet is top of the BATMMAAN food chain, gaining nearly 60% in 2025.

Texas Governor Abbott And Google Make Economic Development Announcement In Midlothian

Latest Stories

Sherwood Media, LLC produces fresh and unique perspectives on topical financial news and is a fully owned subsidiary of Robinhood Markets, Inc., and any views expressed here do not necessarily reflect the views of any other Robinhood affiliate, including Robinhood Markets, Inc., Robinhood Financial LLC, Robinhood Securities, LLC, Robinhood Crypto, LLC, or Robinhood Money, LLC.
©2025 Sherwood Media, LLC